Mexico In Vitro Diagnostics (IVD) Market Outlook to 2024 - Clinical Chemistry, Genetic Testing, Hematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture

Published : Dec-2017

No. of Pages : 455

order by fax Inquire before Buying request discount

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 9
2 Introduction 13
2.1 What Is This Report About? 13
2.2 In Vitro Diagnostics (IVD) Market Segmentation 13
2.3 Definitions of Markets Covered in the Report 17
3 In Vitro Diagnostics Market, Mexico 40
3.1 In Vitro Diagnostics Market, Mexico, Revenue ($m), 2010-2024 40
3.2 In Vitro Diagnostics Market, Mexico, Revenue Mix ($m), 2017 42
3.3 In Vitro Diagnostics Market, Mexico, Category Contribution by Revenue ($m), 2017 43
3.4 In Vitro Diagnostics Market, Mexico, Category Comparison by Revenue ($m), 2009-2023 45
3.5 In Vitro Diagnostics Market, Mexico, Revenue ($m), 2010-2017 47
3.6 In Vitro Diagnostics Market, Mexico, Revenue ($m), 2017-2024 49
3.7 In Vitro Diagnostics Market, Mexico, Volume (Units), 2010-2024 51
3.8 In Vitro Diagnostics Market, Mexico, Volume (Units), 2010-2017 53
3.9 In Vitro Diagnostics Market, Mexico, Volume (Units), 2017-2024 55
3.10 In Vitro Diagnostics Market, Mexico, Company Share by Revenue ($m), 2017 57
4 Clinical Chemistry Market, Mexico 59
4.1 Clinical Chemistry Market, Mexico, Revenue Mix ($m), 2017 59
4.2 Clinical Chemistry Market, Mexico, Segment Contribution (%), 2017 60
4.3 Clinical Chemistry Market, Mexico, Revenue ($m), 2010-2017 62
4.4 Clinical Chemistry Market, Mexico, Revenue ($m), 2017-2024 64
4.5 Clinical Chemistry Market, Mexico, Volume (Units), 2010-2017 98
4.6 Clinical Chemistry Market, Mexico, Volume (Units), 2017-2024 100
4.7 Clinical Chemistry Market, Mexico, Distribution Share by Revenue ($m), 2017 126
4.8 Clinical Chemistry Market, Mexico, Company Share by Revenue ($m), 2017 127
5 Genetic Testing Market, Mexico 129
5.1 Genetic Testing Market, Mexico, Revenue Mix ($m), 2017 129
5.2 Genetic Testing Market, Mexico, Segment Contribution (%), 2017 130
5.3 Genetic Testing Market, Mexico, Revenue ($m), 2010-2017 132
5.4 Genetic Testing Market, Mexico, Revenue ($m), 2017-2024 134
5.5 Genetic Testing Market, Mexico, Distribution Share by Revenue ($m), 2017 136
5.6 Genetic Testing Market, Mexico, Company Share by Revenue ($m), 2017 137
6 Hematology Market, Mexico 139
6.1 Hematology Market, Mexico, Revenue Mix ($m), 2017 139
6.2 Hematology Market, Mexico, Segment Contribution (%), 2017 140
6.3 Hematology Market, Mexico, Revenue ($m), 2010-2017 141
6.4 Hematology Market, Mexico, Revenue ($m), 2017-2024 143
6.5 Hematology Market, Mexico, Volume (Units), 2010-2017 169
6.6 Hematology Market, Mexico, Volume (Units), 2017-2024 171
6.7 Hematology Market, Mexico, Distribution Share by Revenue ($m), 2017 189
6.8 Hematology Market, Mexico, Company Share by Revenue ($m), 2017 190
7 Histology And Cytology Market, Mexico 192
7.1 Histology And Cytology Market, Mexico, Revenue Mix ($m), 2017 192
7.2 Histology And Cytology Market, Mexico, Segment Contribution (%), 2017 193
7.3 Histology And Cytology Market, Mexico, Revenue ($m), 2010-2017 194
7.4 Histology And Cytology Market, Mexico, Revenue ($m), 2017-2024 196
7.5 Histology And Cytology Market, Mexico, Distribution Share by Revenue ($m), 2017 198
7.6 Histology And Cytology Market, Mexico, Company Share by Revenue ($m), 2017 199
8 Immuno Chemistry Market, Mexico 201
8.1 Immuno Chemistry Market, Mexico, Revenue Mix ($m), 2017 201
8.2 Immuno Chemistry Market, Mexico, Segment Contribution (%), 2017 202
8.3 Immuno Chemistry Market, Mexico, Revenue ($m), 2010-2017 204
8.4 Immuno Chemistry Market, Mexico, Revenue ($m), 2017-2024 206
8.5 Immuno Chemistry Market, Mexico, Volume (Units), 2010-2017 240
8.6 Immuno Chemistry Market, Mexico, Volume (Units), 2017-2024 242
8.7 Immuno Chemistry Market, Mexico, Distribution Share by Revenue ($m), 2017 276
8.8 Immuno Chemistry Market, Mexico, Company Share by Revenue ($m), 2017 277
9 Infectious Diagnostics Market, Mexico 279
9.1 Infectious Diagnostics Market, Mexico, Revenue ($m), 2010-2017 279
9.2 Infectious Diagnostics Market, Mexico, Revenue ($m), 2017-2024 282
9.3 Infectious Diagnostics Market, Mexico, Volume (Units), 2010-2017 329
9.4 Infectious Diagnostics Market, Mexico, Volume (Units), 2017-2024 332
9.5 Infectious Diagnostics Market, Mexico, Distribution Share by Revenue ($m), 2017 380
9.6 Infectious Diagnostics Market, Mexico, Company Share by Revenue ($m), 2017 381
10 Microbiology Culture Market, Mexico 383
10.1 Microbiology Culture Market, Mexico, Revenue Mix ($m), 2017 383
10.2 Microbiology Culture Market, Mexico, Segment Contribution (%), 2017 384
10.3 Microbiology Culture Market, Mexico, Revenue ($m), 2010-2017 386
10.4 Microbiology Culture Market, Mexico, Revenue ($m), 2017-2024 388
10.5 Microbiology Culture Market, Mexico, Distribution Share by Revenue ($m), 2017 398
10.6 Microbiology Culture Market, Mexico, Company Share by Revenue ($m), 2017 399
11 Overview of Key Companies in Mexico, In Vitro Diagnostics Market 401
11.1 F. Hoffmann-La Roche Ltd 401
11.2 Beckman Coulter Inc 401
11.3 Abbott Laboratories 401
11.4 Siemens Healthcare GmbH 401
11.5 Becton Dickinson and Co 402
11.6 Thermo Fisher Scientific Inc 402
11.7 bioMerieux SA 402
11.8 Qiagen NV 402
11.9 Hologic Inc 403
11.10 Bio-Rad Laboratories Inc 403
11.11 Horiba Ltd 403
11.12 Sysmex Corp 403
11.13 Cepheid 404
11.14 Ortho-Clinical Diagnostics Inc 404
11.15 Alere Inc 404
11.16 DiaSorin S.p.A 404
12 In Vitro Diagnostics Market Pipeline Products 405
13 Financial Deals Landscape 409
13.1 Acquisition 409
13.2 Asset Transactions 411
13.3 Partnerships 413
14 Appendix 445
14.1 Research Methodology 446
14.2 GlobalData Consulting 450
14.3 Contact Us 451
14.4 Disclaimer 451

1.1 List of Tables
Table 1: In Vitro Diagnostics Market, Mexico, Revenue ($m), USD Constant, 2010-2024 45
Table 2: In Vitro Diagnostics Market, Mexico, Category Contribution by Revenue ($m), 2017 48
Table 3: In Vitro Diagnostics Market, Mexico, Category Comparison by Revenue ($m), 2009-2023 50
Table 4: In Vitro Diagnostics Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 52
Table 5: In Vitro Diagnostics Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 54
Table 6: In Vitro Diagnostics Market, Mexico, Volume (Units), 2010-2024 56
Table 7: In Vitro Diagnostics Market, Mexico, Volume (Units), Historic, 2010-2017 58
Table 8: In Vitro Diagnostics Market, Mexico, Volume (Units), Forecast, 2017-2024 60
Table 9: In Vitro Diagnostics Market, Mexico, Company Share by Revenue ($m), USD Constant, 2017 62
Table 10: Clinical Chemistry Market, Mexico, Segment Contribution (%), 2017 65
Table 11: Clinical Chemistry Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 67
Table 12: Clinical Chemistry Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 69
Table 13: Blood Test Strips - Rapid Tests & POC Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 71
Table 14: Clinical Chemistry Analyzers Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 73
Table 15: Enzyme Chemistry Reagents Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 75
Table 16: Feces Tests - Rapid Tests & POC Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 77
Table 17: Substrates Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 79
Table 18: Therapeutic Drug Monitoring Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 81
Table 19: Urine Analysis Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 83
Table 20: Urine Testing - Rapid Tests & POC Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 85
Table 21: Blood Test Strips - Rapid Tests & POC Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 87
Table 22: Clinical Chemistry Analyzers Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 89
Table 23: Enzyme Chemistry Reagents Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 91
Table 24: Feces Tests - Rapid Tests & POC Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 93
Table 25: Substrates Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 95
Table 26: Therapeutic Drug Monitoring Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 97
Table 27: Urine Analysis Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 99
Table 28: Urine Testing - Rapid Tests & POC Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 101
Table 29: Clinical Chemistry Market, Mexico, Volume (Units), Historic, 2010-2017 103
Table 30: Clinical Chemistry Market, Mexico, Volume (Units), Forecast, 2017-2024 105
Table 31: Blood Test Strips - Rapid Tests & POC Market, Mexico, Volume (Units), Historic, 2010-2017 107
Table 32: Clinical Chemistry Analyzers Market, Mexico, Volume (Units), Historic, 2010-2017 109
Table 33: Enzyme Chemistry Reagents Market, Mexico, Volume (Units), Historic, 2010-2017 111
Table 34: Feces Tests - Rapid Tests & POC Market, Mexico, Volume (Units), Historic, 2010-2017 113
Table 35: Substrates Market, Mexico, Volume (Units), Historic, 2010-2017 115
Table 36: Urine Testing - Rapid Tests & POC Market, Mexico, Volume (Units), Historic, 2010-2017 117
Table 37: Blood Test Strips - Rapid Tests & POC Market, Mexico, Volume (Units), Forecast, 2017-2024 119
Table 38: Clinical Chemistry Analyzers Market, Mexico, Volume (Units), Forecast, 2017-2024 121
Table 39: Enzyme Chemistry Reagents Market, Mexico, Volume (Units), Forecast, 2017-2024 123
Table 40: Feces Tests - Rapid Tests & POC Market, Mexico, Volume (Units), Forecast, 2017-2024 125
Table 41: Substrates Market, Mexico, Volume (Units), Forecast, 2017-2024 127
Table 42: Urine Testing - Rapid Tests & POC Market, Mexico, Volume (Units), Forecast, 2017-2024 129
Table 43: Clinical Chemistry Market, Mexico, Distribution Share by Revenue ($m), USD Constant, 2017 130
Table 44: Clinical Chemistry Market, Mexico, Company Share by Revenue ($m), USD Constant, 2017 132
Table 45: Genetic Testing Market, Mexico, Segment Contribution (%), 2017 135
Table 46: Genetic Testing Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 137
Table 47: Genetic Testing Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 139
Table 48: Genetic Testing Market, Mexico, Distribution Share by Revenue ($m), USD Constant, 2017 140
Table 49: Genetic Testing Market, Mexico, Company Share by Revenue ($m), USD Constant, 2017 142
Table 50: Hematology Market, Mexico, Segment Contribution (%), 2017 144
Table 51: Hematology Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 146
Table 52: Hematology Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 148
Table 53: Hematology Analyzers Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 150
Table 54: Hematology Cell Counters Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 152
Table 55: Hematology Rapid Tests & POC Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 154
Table 56: Hematology Reagents Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 156
Table 57: Hemostasis Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 158
Table 58: Immunohematology Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 160
Table 59: Hematology Analyzers Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 162
Table 60: Hematology Cell Counters Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 164
Table 61: Hematology Rapid Tests & POC Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 166
Table 62: Hematology Reagents Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 168
Table 63: Hemostasis Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 170
Table 64: Immunohematology Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 172
Table 65: Hematology Market, Mexico, Volume (Units), Historic, 2010-2017 174
Table 66: Hematology Market, Mexico, Volume (Units), Forecast, 2017-2024 176
Table 67: Hematology Analyzers Market, Mexico, Volume (Units), Historic, 2010-2017 178
Table 68: Hematology Rapid Tests & POC Market, Mexico, Volume (Units), Historic, 2010-2017 180
Table 69: Hematology Reagents Market, Mexico, Volume (Units), Historic, 2010-2017 182
Table 70: Hemostasis Market, Mexico, Volume (Units), Historic, 2010-2017 184
Table 71: Hematology Analyzers Market, Mexico, Volume (Units), Forecast, 2017-2024 186
Table 72: Hematology Rapid Tests & POC Market, Mexico, Volume (Units), Forecast, 2017-2024 188
Table 73: Hematology Reagents Market, Mexico, Volume (Units), Forecast, 2017-2024 190
Table 74: Hemostasis Market, Mexico, Volume (Units), Forecast, 2017-2024 192
Table 75: Hematology Market, Mexico, Distribution Share by Revenue ($m), USD Constant, 2017 193
Table 76: Hematology Market, Mexico, Company Share by Revenue ($m), USD Constant, 2017 195
Table 77: Histology And Cytology Market, Mexico, Segment Contribution (%), 2017 197
Table 78: Histology And Cytology Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 199
Table 79: Histology And Cytology Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 201
Table 80: Histology And Cytology Market, Mexico, Distribution Share by Revenue ($m), USD Constant, 2017 202
Table 81: Histology And Cytology Market, Mexico, Company Share by Revenue ($m), USD Constant, 2017 204
Table 82: Immuno Chemistry Market, Mexico, Segment Contribution (%), 2017 207
Table 83: Immuno Chemistry Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 209
Table 84: Immuno Chemistry Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 211
Table 85: Complement Deficiency Tests Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 213
Table 86: Diabetes Assays Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 215
Table 87: Disease Specific Immunochemistry Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 217
Table 88: Endocrinology Tests Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 219
Table 89: IgE Allergy Blood Tests Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 221
Table 90: Immunochemistry Analyzers Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 223
Table 91: Immunochemistry Rapid Tests & POC Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 225
Table 92: Vitamins Tests Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 227
Table 93: Complement Deficiency Tests Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 229
Table 94: Diabetes Assays Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 231
Table 95: Disease Specific Immunochemistry Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 233
Table 96: Endocrinology Tests Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 235
Table 97: IgE Allergy Blood Tests Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 237
Table 98: Immunochemistry Analyzers Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 239
Table 99: Immunochemistry Rapid Tests & POC Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 241
Table 100: Vitamins Tests Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 243
Table 101: Immuno Chemistry Market, Mexico, Volume (Units), Historic, 2010-2017 245
Table 102: Immuno Chemistry Market, Mexico, Volume (Units), Forecast, 2017-2024 247
Table 103: Complement Deficiency Tests Market, Mexico, Volume (Units), Historic, 2010-2017 249
Table 104: Diabetes Assays Market, Mexico, Volume (Units), Historic, 2010-2017 251
Table 105: Disease Specific Immunochemistry Market, Mexico, Volume (Units), Historic, 2010-2017 253
Table 106: Endocrinology Tests Market, Mexico, Volume (Units), Historic, 2010-2017 255
Table 107: IgE Allergy Blood Tests Market, Mexico, Volume (Units), Historic, 2010-2017 257
Table 108: Immunochemistry Analyzers Market, Mexico, Volume (Units), Historic, 2010-2017 259
Table 109: Immunochemistry Rapid Tests & POC Market, Mexico, Volume (Units), Historic, 2010-2017 261
Table 110: Vitamins Tests Market, Mexico, Volume (Units), Historic, 2010-2017 263
Table 111: Complement Deficiency Tests Market, Mexico, Volume (Units), Forecast, 2017-2024 265
Table 112: Diabetes Assays Market, Mexico, Volume (Units), Forecast, 2017-2024 267
Table 113: Disease Specific Immunochemistry Market, Mexico, Volume (Units), Forecast, 2017-2024 269
Table 114: Endocrinology Tests Market, Mexico, Volume (Units), Forecast, 2017-2024 271
Table 115: IgE Allergy Blood Tests Market, Mexico, Volume (Units), Forecast, 2017-2024 273
Table 116: Immunochemistry Analyzers Market, Mexico, Volume (Units), Forecast, 2017-2024 275
Table 117: Immunochemistry Rapid Tests & POC Market, Mexico, Volume (Units), Forecast, 2017-2024 277
Table 118: Vitamins Tests Market, Mexico, Volume (Units), Forecast, 2017-2024 279
Table 119: Immuno Chemistry Market, Mexico, Distribution Share by Revenue ($m), USD Constant, 2017 280
Table 120: Immuno Chemistry Market, Mexico, Company Share by Revenue ($m), USD Constant, 2017 282
Table 121: Infectious Diagnostics Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 284
Table 122: Infectious Diagnostics Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 287
Table 123: Chlamydia trichomatis Diagnostic Test Kits Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 290
Table 124: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 292
Table 125: Hepatitis Test Kits Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 294
Table 126: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 296
Table 127: Infectious Diagnostics Multiple Parameter Test Kits Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 298
Table 128: Infectious Diagnostics Rapid Tests & POC Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 300
Table 129: Mycobacterium tuberculosis Diagnostic Tests Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 302
Table 130: Polymerase Chain Reaction (PCR) Systems Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 304
Table 131: Post Streptococcus pyogenes Diagnostic Tests Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 306
Table 132: Retrovirus Tests Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 308
Table 133: Treponema pallidum Diagnostic Tests Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 310
Table 134: Chlamydia trichomatis Diagnostic Test Kits Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 312
Table 135: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 314
Table 136: Hepatitis Test Kits Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 316
Table 137: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 318
Table 138: Infectious Diagnostics Multiple Parameter Test Kits Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 320
Table 139: Infectious Diagnostics Rapid Tests & POC Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 322
Table 140: Mycobacterium tuberculosis Diagnostic Tests Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 324
Table 141: Polymerase Chain Reaction (PCR) Systems Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 326
Table 142: Post Streptococcus pyogenes Diagnostic Tests Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 328

1.2 List of Figures
Figure 1: In Vitro Diagnostics Market, Mexico, Revenue ($m), USD Constant, 2010-2024 44
Figure 2: In Vitro Diagnostics Market, Mexico, Revenue Mix ($m), 2017 46
Figure 3: In Vitro Diagnostics Market, Mexico, Category Contribution (%), 2017 47
Figure 4: In Vitro Diagnostics Market, Mexico, Category Comparison by Revenue ($m), 2009-2023 49
Figure 5: In Vitro Diagnostics Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 51
Figure 6: In Vitro Diagnostics Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 53
Figure 7: In Vitro Diagnostics Market, Mexico, Volume (Units), 2010-2024 55
Figure 8: In Vitro Diagnostics Market, Mexico, Volume (Units), Historic, 2010-2017 57
Figure 9: In Vitro Diagnostics Market, Mexico, Volume (Units), Forecast, 2017-2024 59
Figure 10: In Vitro Diagnostics Market, Mexico, Company Share (%) 2017 61
Figure 11: Clinical Chemistry Market, Mexico, Revenue Mix ($m), 2017 63
Figure 12: Clinical Chemistry Market, Mexico, Segment Contribution (%), 2017 64
Figure 13: Clinical Chemistry Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 66
Figure 14: Clinical Chemistry Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 68
Figure 15: Blood Test Strips - Rapid Tests & POC Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 70
Figure 16: Clinical Chemistry Analyzers Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 72
Figure 17: Enzyme Chemistry Reagents Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 74
Figure 18: Feces Tests - Rapid Tests & POC Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 76
Figure 19: Substrates Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 78
Figure 20: Therapeutic Drug Monitoring Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 80
Figure 21: Urine Analysis Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 82
Figure 22: Urine Testing - Rapid Tests & POC Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 84
Figure 23: Blood Test Strips - Rapid Tests & POC Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 86
Figure 24: Clinical Chemistry Analyzers Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 88
Figure 25: Enzyme Chemistry Reagents Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 90
Figure 26: Feces Tests - Rapid Tests & POC Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 92
Figure 27: Substrates Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 94
Figure 28: Therapeutic Drug Monitoring Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 96
Figure 29: Urine Analysis Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 98
Figure 30: Urine Testing - Rapid Tests & POC Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 100
Figure 31: Clinical Chemistry Market, Mexico, Volume (Units), Historic, 2010-2017 102
Figure 32: Clinical Chemistry Market, Mexico, Volume (Units), Forecast, 2017-2024 104
Figure 33: Blood Test Strips - Rapid Tests & POC Market, Mexico, Volume (Units), Historic, 2010-2017 106
Figure 34: Clinical Chemistry Analyzers Market, Mexico, Volume (Units), Historic, 2010-2017 108
Figure 35: Enzyme Chemistry Reagents Market, Mexico, Volume (Units), Historic, 2010-2017 110
Figure 36: Feces Tests - Rapid Tests & POC Market, Mexico, Volume (Units), Historic, 2010-2017 112
Figure 37: Substrates Market, Mexico, Volume (Units), Historic, 2010-2017 114
Figure 38: Urine Testing - Rapid Tests & POC Market, Mexico, Volume (Units), Historic, 2010-2017 116
Figure 39: Blood Test Strips - Rapid Tests & POC Market, Mexico, Volume (Units), Forecast, 2017-2024 118
Figure 40: Clinical Chemistry Analyzers Market, Mexico, Volume (Units), Forecast, 2017-2024 120
Figure 41: Enzyme Chemistry Reagents Market, Mexico, Volume (Units), Forecast, 2017-2024 122
Figure 42: Feces Tests - Rapid Tests & POC Market, Mexico, Volume (Units), Forecast, 2017-2024 124
Figure 43: Substrates Market, Mexico, Volume (Units), Forecast, 2017-2024 126
Figure 44: Urine Testing - Rapid Tests & POC Market, Mexico, Volume (Units), Forecast, 2017-2024 128
Figure 45: Clinical Chemistry Market, Mexico, Company Share (%) 2017 131
Figure 46: Genetic Testing Market, Mexico, Revenue Mix ($m), 2017 133
Figure 47: Genetic Testing Market, Mexico, Segment Contribution (%), 2017 134
Figure 48: Genetic Testing Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 136
Figure 49: Genetic Testing Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 138
Figure 50: Genetic Testing Market, Mexico, Company Share (%) 2017 141
Figure 51: Hematology Market, Mexico, Revenue Mix ($m), 2017 143
Figure 52: Hematology Market, Mexico, Segment Contribution (%), 2017 144
Figure 53: Hematology Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 145
Figure 54: Hematology Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 147
Figure 55: Hematology Analyzers Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 149
Figure 56: Hematology Cell Counters Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 151
Figure 57: Hematology Rapid Tests & POC Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 153
Figure 58: Hematology Reagents Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 155
Figure 59: Hemostasis Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 157
Figure 60: Immunohematology Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 159
Figure 61: Hematology Analyzers Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 161
Figure 62: Hematology Cell Counters Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 163
Figure 63: Hematology Rapid Tests & POC Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 165
Figure 64: Hematology Reagents Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 167
Figure 65: Hemostasis Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 169
Figure 66: Immunohematology Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 171
Figure 67: Hematology Market, Mexico, Volume (Units), Historic, 2010-2017 173
Figure 68: Hematology Market, Mexico, Volume (Units), Forecast, 2017-2024 175
Figure 69: Hematology Analyzers Market, Mexico, Volume (Units), Historic, 2010-2017 177
Figure 70: Hematology Rapid Tests & POC Market, Mexico, Volume (Units), Historic, 2010-2017 179
Figure 71: Hematology Reagents Market, Mexico, Volume (Units), Historic, 2010-2017 181
Figure 72: Hemostasis Market, Mexico, Volume (Units), Historic, 2010-2017 183
Figure 73: Hematology Analyzers Market, Mexico, Volume (Units), Forecast, 2017-2024 185
Figure 74: Hematology Rapid Tests & POC Market, Mexico, Volume (Units), Forecast, 2017-2024 187
Figure 75: Hematology Reagents Market, Mexico, Volume (Units), Forecast, 2017-2024 189
Figure 76: Hemostasis Market, Mexico, Volume (Units), Forecast, 2017-2024 191
Figure 77: Hematology Market, Mexico, Company Share (%) 2017 194
Figure 78: Histology And Cytology Market, Mexico, Revenue Mix ($m), 2017 196
Figure 79: Histology And Cytology Market, Mexico, Segment Contribution (%), 2017 197
Figure 80: Histology And Cytology Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 198
Figure 81: Histology And Cytology Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 200
Figure 82: Histology And Cytology Market, Mexico, Company Share (%) 2017 203
Figure 83: Immuno Chemistry Market, Mexico, Revenue Mix ($m), 2017 205
Figure 84: Immuno Chemistry Market, Mexico, Segment Contribution (%), 2017 206
Figure 85: Immuno Chemistry Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 208
Figure 86: Immuno Chemistry Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 210
Figure 87: Complement Deficiency Tests Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 212
Figure 88: Diabetes Assays Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 214
Figure 89: Disease Specific Immunochemistry Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 216
Figure 90: Endocrinology Tests Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 218
Figure 91: IgE Allergy Blood Tests Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 220
Figure 92: Immunochemistry Analyzers Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 222
Figure 93: Immunochemistry Rapid Tests & POC Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 224
Figure 94: Vitamins Tests Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 226
Figure 95: Complement Deficiency Tests Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 228
Figure 96: Diabetes Assays Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 230
Figure 97: Disease Specific Immunochemistry Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 232
Figure 98: Endocrinology Tests Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 234
Figure 99: IgE Allergy Blood Tests Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 236
Figure 100: Immunochemistry Analyzers Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 238
Figure 101: Immunochemistry Rapid Tests & POC Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 240
Figure 102: Vitamins Tests Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 242
Figure 103: Immuno Chemistry Market, Mexico, Volume (Units), Historic, 2010-2017 244
Figure 104: Immuno Chemistry Market, Mexico, Volume (Units), Forecast, 2017-2024 246
Figure 105: Complement Deficiency Tests Market, Mexico, Volume (Units), Historic, 2010-2017 248
Figure 106: Diabetes Assays Market, Mexico, Volume (Units), Historic, 2010-2017 250
Figure 107: Disease Specific Immunochemistry Market, Mexico, Volume (Units), Historic, 2010-2017 252
Figure 108: Endocrinology Tests Market, Mexico, Volume (Units), Historic, 2010-2017 254
Figure 109: IgE Allergy Blood Tests Market, Mexico, Volume (Units), Historic, 2010-2017 256
Figure 110: Immunochemistry Analyzers Market, Mexico, Volume (Units), Historic, 2010-2017 258
Figure 111: Immunochemistry Rapid Tests & POC Market, Mexico, Volume (Units), Historic, 2010-2017 260
Figure 112: Vitamins Tests Market, Mexico, Volume (Units), Historic, 2010-2017 262
Figure 113: Complement Deficiency Tests Market, Mexico, Volume (Units), Forecast, 2017-2024 264
Figure 114: Diabetes Assays Market, Mexico, Volume (Units), Forecast, 2017-2024 266
Figure 115: Disease Specific Immunochemistry Market, Mexico, Volume (Units), Forecast, 2017-2024 268
Figure 116: Endocrinology Tests Market, Mexico, Volume (Units), Forecast, 2017-2024 270
Figure 117: IgE Allergy Blood Tests Market, Mexico, Volume (Units), Forecast, 2017-2024 272
Figure 118: Immunochemistry Analyzers Market, Mexico, Volume (Units), Forecast, 2017-2024 274
Figure 119: Immunochemistry Rapid Tests & POC Market, Mexico, Volume (Units), Forecast, 2017-2024 276
Figure 120: Vitamins Tests Market, Mexico, Volume (Units), Forecast, 2017-2024 278
Figure 121: Immuno Chemistry Market, Mexico, Company Share (%) 2017 281
Figure 122: Infectious Diagnostics Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 283
Figure 123: Infectious Diagnostics Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 286
Figure 124: Chlamydia trichomatis Diagnostic Test Kits Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 289
Figure 125: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 291
Figure 126: Hepatitis Test Kits Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 293
Figure 127: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 295
Figure 128: Infectious Diagnostics Multiple Parameter Test Kits Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 297
Figure 129: Infectious Diagnostics Rapid Tests & POC Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 299
Figure 130: Mycobacterium tuberculosis Diagnostic Tests Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 301
Figure 131: Polymer

Filed in: In Vitro Diagnostic, Medical Device

Publisher : GlobalData

Name:
Email:
Phone:
Subject:
Comments:

More Reports

Title	Price	Buy Now
In Vitro Fertilization /IVF Market by Product (Micromanipulators, Incubators, Cabinets, Imaging System, Laser System, Reagents & Accessories), Type (Conventional IVF, IVF with ICSI), End User (Fertility Clinics, Hospitals, Cryobanks) – Global Forecast to 2026 “The global in vitro fertilization market size is projected to reach USD 987 million by 2026 from USD 638 million in 2021, at a CAGR of 9.1 % during the forecast period” The global in vitro fertilization market is projected to reach USD 987 million by 2026 from USD 638 million in 2021, at a CAGR of 9.1% from 2021 to 2026. The key factors fueling the growth of this market include an increase in the median age of first-time mothers, declining fertility rates, rising male infertility, rise in obesity rate and growing consumption of alcohol, and growing awareness about the availability of treatment options. However, the high cost and low success rate of IVF treatment and restrictive regulations and ethical concerns are expected to restrict the growth of the IVF market to a certain e......	$4950
Assisted Reproductive Technology Devices (General Surgery) – Global Market Analysis and Forecast Model (COVID-19 market impact) Assisted Reproductive Technology Devices (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 market impact) Summary Assisted Reproductive Technology Devices (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market trends within General Surgery therapeutic area. The model discusses in detail the impact of COVID-19 on Assisted Reproductive Technology Devices market for the year 2020 and beyond. Assisted Reproductive Technology (ART) refers to reproductive health procedures that treat infertile women to achieve pregnancy. For decades now across much of the developed world, several techniques of ART have been in use with varying pregnancy success rates. These techniques primarily include, but are no......	$7500
Multiparameter CT/NG NAAT Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model (COVID-19 Market Impact) Multiparameter CT/NG NAAT Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 Market Impact) Summary Multiparameter CT/NG NAAT Tests (In Vitro Diagnostics) - Global Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. The model discusses in detail the impact of COVID-19 on Multiparameter CT/NG NAAT Tests market for the year 2020 and beyond. Chlamydia is a common sexually transmissible disease, caused by the bacteria Chlamydia Trachomatis. In women, Chlamydia Trachomatis infections are often asymptomatic, however, if left untreated they can cause pelvic inflammatory disease (PID), which in turn can lead to additional complications such as infertility, ectopic preg......	$7500
Hemophilia A and B – Global Drug Forecast and Market Analysis to 2028 Hemophilia A and B - Global Drug Forecast and Market Analysis to 2028 Summary Hemophilia A and B are rare, genetic, X-linked deficiencies in the blood clotting factors VIII (FVIII) and IX (FIX), respectively. Patients can be categorized as mild, moderate or severe depending on the percentage of circulating FVIII or FIX in their blood. Patients can be treated either on-demand or prophylactically using plasma-derived or recombinant replacement factors, the current standard of care. Although these therapies are effective, they are associated with a great treatment burden. There is a significant unmet need for new therapies that can reduce the great treatment burden associated with intravenous administration, the frequency of prophylactic infusions, and the risk of developing neutralizing a......	$10995
Human Immunodeficiency Virus (HIV) Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model Human Immunodeficiency Virus (HIV) Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model Summary Human Immunodeficiency Virus (HIV) Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Human Immunodeficiency Virus (HIV) has become one of the world's most serious health issues affecting approximately 36.9 million people. The epidemiology of HIV infections varies from one geographical region to another. Sources indicate that in many countries, incidence rates for HIV have stabilized due to the campaigns that provide condoms, pre-exposure prophylaxis, sterile needles, syringes, antiretroviral therapy (ART), and prevention of mother-to-child transmission interv......	$7500
Chlamydia Trachomatis Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model Chlamydia Trachomatis Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model Summary Chlamydia Trachomatis Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Chlamydia is a common sexually transmissible disease, caused by the bacteria Chlamydia trachomatis. Patient access to Chlamydia screening, and thus the number of reported cases, varies substantially between countries. In some countries annual screening is recommended for specific patient groups deemed to be at higher risk of contracting the disease, such as sexually active females younger than 25 years. Additionally, screening of pregnant women for Chlamydia Trachomatis infections is currently recomme......	$7500
EGFR Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model EGFR Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model Summary EGFR Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Globally, lung cancer is the second most common cancer in men and the third most common cancer in women. There are two main types of lung cancer; small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC), with NSCLC accounting for approximately 80-90% of all lung cancer cases. The 5-year survival rate for patients with stage IV disease is less than 5% as majority of patients present with the advanced or metastatic disease at diagnosis. EGFR is a member of the receptor tyrosine kinase family and a major factor in regulating ......	$7500
Human Papilloma Virus (HPV) Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model Human Papilloma Virus (HPV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model Summary Human Papilloma Virus (HPV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Cervical cancer screening has traditionally been based on cervical cytology. In recent years however, many countries have incorporated Human Papilloma Virus (HPV) tests into their cervical cancer and pre-cancer screening programs. Cytology based screening programs require a well-established healthcare infrastructure for processing and interpretation of samples. It is hoped that HPV screening methods may enable better prevention of these disease, these devices are also highly sensitive an......	$7500
Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model "Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model Summary Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Cytomegalovirus (CMV) represents the most common congenital, viral infection in the developed world and awareness of this disease is increasing. Few countries have official guidelines in place for CMV screening but in general testing tends to be performed for sperm donations, immunocompromised cases, and pregnant women. Diagnosis of CMV infections is complex as symptoms are often non-specific and mimic mononucleosis or the flu. Approximately 21-25% of primary CMV infections are symptomatic ......	$7500
Hematology Analyzers (In Vitro Diagnostics) – Global Market Analysis and Forecast Model Hematology Analyzers (In Vitro Diagnostics) - Global Market Analysis and Forecast Model Summary Hematology Analyzers (In Vitro Diagnostics) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. The market for automated Hematology Analyzers is increasing due to their reliability, advanced quality and fast testing mechanisms. The Hematology Analyzer market also benefits from rises in the prevalence of anaemia, increased incidence of blood related diseases and disorders, and the growing importance of blood cell counts in routine diagnostic procedures for patient treatment and monitoring. In developed and developing countries, hematology analyzers are installed in both hospital and reference laboratory set......	$7500

Mexico In Vitro Diagnostics (IVD) Market Outlook to 2024 - Clinical Chemistry, Genetic Testing, Hematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture

Benefits of Sandler Research

User License for Reports

Reach Us

Contact Us

Knowledge Store

Email Subscription

our Feed Reader

In Vitro Fertilization /IVF Market by Product (Micromanipulators, Incubators, Cabinets, Imaging System, Laser System, Reagents & Accessories), Type (Conventional IVF, IVF with ICSI), End User (Fertility Clinics, Hospitals, Cryobanks) – Global Forecast to 2026

Assisted Reproductive Technology Devices (General Surgery) – Global Market Analysis and Forecast Model (COVID-19 market impact)

Multiparameter CT/NG NAAT Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model (COVID-19 Market Impact)

Hemophilia A and B – Global Drug Forecast and Market Analysis to 2028

Human Immunodeficiency Virus (HIV) Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model

Chlamydia Trachomatis Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model

EGFR Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model

Human Papilloma Virus (HPV) Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model

Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model

Hematology Analyzers (In Vitro Diagnostics) – Global Market Analysis and Forecast Model